60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
02/05/25, 2:25 PM
Location
washingtonMoney
$1.08 million
Industry
manufacturing
Type
partnership
60 Degrees Pharmaceuticals, Inc. has announced a registered direct offering priced at-the-market under Nasdaq rules. The company intends to use the net proceeds from the offering for working capital and other general corporate purposes.
Company Info
Location
1025 connecticut avenue nw
washington, district of columbia, united states
Additional Info
60 Degrees Pharmaceuticals, INC develops and commercializes new medicines to treat and prevent infectious diseases with a product focus on ARAKODA for malaria prevention, and a research focus on tickborne disease.